BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16330423)

  • 1. Prognostic value of minimal residual disease monitoring in acute myeloid leukemia patients with t(9;11)(p22;q23).
    Tobal K
    Haematologica; 2005 Dec; 90(12):1586A. PubMed ID: 16330423
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
    Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
    Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
    Scholl C; Breitinger H; Schlenk RF; Döhner H; Fröhling S; Döhner K;
    Genes Chromosomes Cancer; 2003 Nov; 38(3):274-80. PubMed ID: 14506704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.
    Lou Z; Zhang CC; Tirado CA; Slone T; Zheng J; Zaremba CM; Oliver D; Chen W
    Leuk Res; 2010 Aug; 34(8):1107-9. PubMed ID: 20299091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia.
    Abdelhaleem M; Yi Q; Beimnet K; Grant R
    Am J Hematol; 2007 Mar; 82(3):247. PubMed ID: 16924642
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
    Piccaluga PP; Martinelli G; Malagola M; Rondoni M; Bianchini M; Visani G; Baccarani M
    Haematologica; 2003 Aug; 88(8):ECR28. PubMed ID: 12935987
    [No Abstract]   [Full Text] [Related]  

  • 7. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
    de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
    Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
    Tobal K; Frost L; Liu Yin JA
    Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia.
    Panagopoulos I; Lilljebjörn H; Strömbeck B; Hjorth L; Olofsson T; Johansson B
    Haematologica; 2006 Sep; 91(9):1287-8. PubMed ID: 16956839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in infants with acute myeloid leukemia.
    Pui CH; Raimondi SC; Srivastava DK; Tong X; Behm FG; Razzouk B; Rubnitz JE; Sandlund JT; Evans WE; Ribeiro R
    Leukemia; 2000 Apr; 14(4):684-7. PubMed ID: 10764155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.
    Buccisano F; Maurillo L; Del Poeta G; Gattei V; Amadori S; Venditti A
    Haematologica; 2006 Dec; 91(12 Suppl):ELT14; author reply ELT15. PubMed ID: 17194674
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia.
    Kakihana K; Kubo F; Wakabayashi S; Kurosu T; Miki T; Murakami N; Miura O
    Cancer Genet Cytogenet; 2008 Jul; 184(2):109-12. PubMed ID: 18617060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.
    Lundin C; Horvat A; Karlsson K; Olofsson T; Paulsson K; Johansson B
    Leuk Res; 2011 Jun; 35(6):e75-6. PubMed ID: 21168209
    [No Abstract]   [Full Text] [Related]  

  • 14. PML/RARA rearrangement associated with a t(15;19;17) in a case of acute myeloid leukemia with abundant myelocytes with salmon-pink cytoplasm.
    Kim IS; Kim HJ; Choung HS; Jung CW; Kim JW; Kim SH
    Cancer Genet Cytogenet; 2006 Aug; 169(1):81-2. PubMed ID: 16875944
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of CBFB-MYH11 fusion gene levels in paired peripheral blood and bone marrow samples by real-time PCR.
    Boeckx N; De Roover J; van der Velden VH; Maertens J; Uyttebroeck A; Vandenberghe P; van Dongen JJ
    Leukemia; 2005 Nov; 19(11):1988-90. PubMed ID: 16193088
    [No Abstract]   [Full Text] [Related]  

  • 16. A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.
    Østergaard M; Stentoft J; Hokland P
    Leuk Res; 2004 Nov; 28(11):1213-5. PubMed ID: 15380347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Acute Myeloid Leukemia with Novel Translocation t(6;11)(p22.2;q23) and Concurrent Insertion ins(11;9)(q23;p21.3p21.3).
    Malinowska I; Sikorska-Fic B; Romiszewska M; Stefaniak A; Pastwińska A; Górska E; Popko K; Meyer C; Marschalek R; Szczepański T
    Adv Exp Med Biol; 2017; 1021():93-98. PubMed ID: 28785923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism.
    Stasevich I; Utskevich R; Kustanovich A; Litvinko N; Savitskaya T; Chernyavskaya S; Saharova O; Aleinikova O
    Cancer Genet Cytogenet; 2006 Sep; 169(2):114-20. PubMed ID: 16938568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?
    Potenza L; Luppi M; Riva G; Ottaviani E; Zucchini P; Morselli M; Volzone F; Forghieri F; Martinelli G; Torelli G
    Leuk Res; 2007 Feb; 31(2):269-71. PubMed ID: 16759701
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
    Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M
    Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.